Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial.

Faseru B, Ellerbeck EF, Catley D, Gajewski BJ, Scheuermann TS, Shireman TI, Mussulman LM, Nazir N, Bush T, Richter KP.

Trials. 2017 Aug 14;18(1):379. doi: 10.1186/s13063-017-2119-9.

2.

Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.

Taylor KL, Hagerman CJ, Luta G, Bellini PG, Stanton C, Abrams DB, Kramer JA, Anderson E, Regis S, McKee A, McKee B, Niaura R, Harper H, Ramsaier M.

Lung Cancer. 2017 Jun;108:242-246. doi: 10.1016/j.lungcan.2017.01.020. Epub 2017 Feb 15.

PMID:
28216065
3.

Comparative effectiveness of motivation phase intervention components for use with smokers unwilling to quit: a factorial screening experiment.

Cook JW, Collins LM, Fiore MC, Smith SS, Fraser D, Bolt DM, Baker TB, Piper ME, Schlam TR, Jorenby D, Loh WY, Mermelstein R.

Addiction. 2016 Jan;111(1):117-28. doi: 10.1111/add.13161. Epub 2015 Nov 19.

4.

Enhancing the effectiveness of smoking treatment research: conceptual bases and progress.

Baker TB, Collins LM, Mermelstein R, Piper ME, Schlam TR, Cook JW, Bolt DM, Smith SS, Jorenby DE, Fraser D, Loh WY, Theobald WE, Fiore MC.

Addiction. 2016 Jan;111(1):107-16. doi: 10.1111/add.13154. Epub 2015 Nov 19.

5.

Treating more smokers, more of the time, more successfully.

Baker TB, Fiore MC.

Addiction. 2015 Mar;110(3):388-9. doi: 10.1111/add.12801. No abstract available.

6.

Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial.

Gonzales D, Hajek P, Pliamm L, Nackaerts K, Tseng LJ, McRae TD, Treadow J.

Clin Pharmacol Ther. 2014 Sep;96(3):390-6. doi: 10.1038/clpt.2014.124. Epub 2014 Jun 9.

7.

Cigarette smoking among patients with chronic diseases.

Campos Tda S, Richter KP, Cupertino AP, Galil AG, Banhato EF, Colugnati FA, Bastos MG.

Int J Cardiol. 2014 Jul 1;174(3):808-10. doi: 10.1016/j.ijcard.2014.04.150. Epub 2014 Apr 22. No abstract available.

8.

Rates and predictors of renewed quitting after relapse during a one-year follow-up among primary care patients.

Bold KW, Rasheed AS, McCarthy DE, Jackson TC, Fiore MC, Baker TB.

Ann Behav Med. 2015 Feb;49(1):128-40. doi: 10.1007/s12160-014-9627-6.

9.

Ongoing self-engagement in quit attempts and cessation outcomes among rural smokers who were unable to quit after 2 years of repeated interventions.

Hui SK, Nazir N, Faseru B, Ellerbeck EF.

J Rural Health. 2013 Winter;29(1):106-12. doi: 10.1111/j.1748-0361.2012.00415.x. Epub 2012 May 31.

10.

Predictors of cessation in African American light smokers enrolled in a bupropion clinical trial.

Faseru B, Nollen NL, Mayo MS, Krebill R, Choi WS, Benowitz NL, Tyndale RF, Okuyemi KS, Ahluwalia JS, Sanderson Cox L.

Addict Behav. 2013 Mar;38(3):1796-803. doi: 10.1016/j.addbeh.2012.11.010. Epub 2012 Nov 29.

11.

State quitlines and cessation patterns among adults with selected chronic diseases in 15 states, 2005-2008.

Bush T, Zbikowski SM, Mahoney L, Deprey M, Mowery P, Cerutti B.

Prev Chronic Dis. 2012;9:E163. doi: 10.5888/pcd9.120105.

12.

Simultaneous evaluation of abstinence and relapse using a Markov chain model in smokers enrolled in a two-year randomized trial.

Yeh HW, Ellerbeck EF, Mahnken JD.

BMC Med Res Methodol. 2012 Jul 7;12:95. doi: 10.1186/1471-2288-12-95.

13.

Efficacy of smoking-cessation interventions for young adults: a meta-analysis.

Suls JM, Luger TM, Curry SJ, Mermelstein RJ, Sporer AK, An LC.

Am J Prev Med. 2012 Jun;42(6):655-62. doi: 10.1016/j.amepre.2012.02.013.

14.

Chronic disease management for tobacco dependence: a randomized, controlled trial.

Joseph AM, Fu SS, Lindgren B, Rothman AJ, Kodl M, Lando H, Doyle B, Hatsukami D.

Arch Intern Med. 2011 Nov 28;171(21):1894-900. doi: 10.1001/archinternmed.2011.500.

15.

Change in self-efficacy, autonomous and controlled motivation predicting smoking.

Cupertino AP, Berg C, Gajewski B, Hui SK, Richter K, Catley D, Ellerbeck EF.

J Health Psychol. 2012 Jul;17(5):640-52. doi: 10.1177/1359105311422457. Epub 2011 Nov 10.

16.

Offering population-based tobacco treatment in a healthcare setting: a randomized controlled trial.

Rigotti NA, Bitton A, Kelley JK, Hoeppner BB, Levy DE, Mort E.

Am J Prev Med. 2011 Nov;41(5):498-503. doi: 10.1016/j.amepre.2011.07.022.

17.

Predictors of early versus late smoking abstinence within a 24-month disease management program.

Cox LS, Wick JA, Nazir N, Cupertino AP, Mussulman LM, Ahluwalia JS, Ellerbeck EF.

Nicotine Tob Res. 2011 Mar;13(3):215-20. doi: 10.1093/ntr/ntq227. Epub 2011 Jan 13.

18.

Implementation of the Tobacco Tactics program in the Department of Veterans Affairs.

Duffy SA, Karvonen-Gutierrez CA, Ewing LA, Smith PM; Veterans Integrated Services Network 11 Tobacco Tactics Team.

J Gen Intern Med. 2010 Jan;25 Suppl 1:3-10. doi: 10.1007/s11606-009-1075-9.

19.

The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study.

Cupertino AP, Wick JA, Richter KP, Mussulman L, Nazir N, Ellerbeck EF.

Arch Intern Med. 2009 Nov 9;169(20):1928-30. doi: 10.1001/archinternmed.2009.355. No abstract available.

Supplemental Content

Support Center